A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ACEIs / angiotensin-converting enzyme inhibitors

[Related PubMed/MEDLINE]
Total Number of Papers: 1014
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ACEIs  (>> Co-occurring Abbreviation)
Long Form:   angiotensin-converting enzyme inhibitors
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A retrospective cohort analysis of the effects of renin-angiotensin system inhibitors on spinal fusion in ACDF patients. ACDF, ARBs, CT, mJOA, RAS
2019 Acupuncture therapy for essential hypertension: a network meta-analysis. ARBs, CBM, CCB, CI, CNKI, DBP, MACE, MD, OR, SBP
2019 Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study. AAs, ARBs, BBs, CI, HF, HR, MPR, PAI, PDC
2019 Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers. ARBs, CRC, RFS
2019 Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan. ARBs, CV
2019 Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population. ARBs, CKD
2019 Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis. ARBs, HF, MI, RCTs
2019 Assessment of hypertension control and factors associated with the control among hypertensive patients attending at Zewditu Memorial Hospital: a cross sectional study. BBs, BP, CCBs
2019 Association of Angiotensin-Converting Enzyme Inhibitors with Increased Mortality Among Patients with Isolated Severe Traumatic Brain Injury. AIS, BBs, TBI
10  2019 Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing. ARBs, CGs, LMWHs, RAS, SNS
11  2019 Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors: a population-based study. ARBs, PDC
12  2019 Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension. ARBs
13  2019 Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis. ARBs, BP, CCBs, CI, CV, GFR, HTN, MD, RAS, RCTs, RR
14  2019 Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis. ARBs, CCBs, NOD, RCTs
15  2019 Comparing the Efficacy of Angiotensin Converting Enzyme Inhibitors with Calcium Channel Blockers on the Treatment of Diabetic Nephropathy: A Meta-Analysis. CCBs, DBP, GFR, MD, RCTs, SBP, SMD, UAER
16  2019 Development of an electronic health record-based chronic kidney disease registry to promote population health management. ARBs, CKD, eGFR, EHR, ESRD, HBV, PHS
17  2019 Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients. ARBs, CIs, CPRD, RRs
18  2019 Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme. DPP-4, GLP-1
19  2019 Distinct effects of antihypertensives on depression in the real-world setting: A retrospective cohort study. ARBs, BBs, CCBs, DIUs
20  2019 Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials. AE, MD, RCTs, RR
21  2019 Environmental and individual predictors of medication adherence among elderly patients with hypertension and chronic kidney disease: A geospatial approach. ARBs, CKD, GWR, PDC
22  2019 Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction. AAs, ARBs, BBs, GDMT, HFrEF
23  2019 Evaluation of drugs used in chronic heart failure at tertiary care centre: a hospital based study. ARBs, BBs, CHF, MRAs, NYHA
24  2019 Expression of the intrarenal angiotensin receptor and the role of renin-angiotensin system inhibitors in IgA nephropathy. ARBs, AT1R, AT2R, IgAN, MASR, RAS
25  2019 Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans. AAs, dCCBs, LV, LVM, RWT, SNP, TDs
26  2019 Hepatotoxicity effect of short-term Bradykinin potentiating factor in cholestatic rats. BDL, BPF
27  2019 Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis. ARBs, BBs, CENTRAL, HF, RCTs, RR
28  2019 Idiopathic Intestinal Angioedema: A Diagnostic Dilemma. IgE
29  2019 Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial). ARBs, RASi
30  2019 Improvement of the outcome in patients with infantile dilated cardiomyopathy over three decades - The usefulness of long-term gradually medical supportive care. CE, DCM
31  2019 Interactive and potentially independent roles of renin-angiotensin-aldosterone system blockade and the development of cardiorenal syndrome type 1 on in-hospital mortality among elderly patients admitted with acute decompensated congestive heart failure. ADCHF, CRS1
32  2019 Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used? ARBs, CKD, ESRD, HR
33  2019 Is preoperative chemoradiation in rectal cancer patients modulated by ACE inhibitors? Results from the Dutch Cancer Registry. ARBs, pCR
34  2019 Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study). ARBs
35  2019 Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study. ARBs, OR, STEMI
36  2019 Macroglossia secondary to lisinopril-induced acute angioedema. ---
37  2019 Managing hypertension in patients with heart failure: an ongoing quandary. BP, HTN
38  2019 Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study. ARB, CI
39  2019 Patient Awareness, Prevalence, and Risk Factors of Chronic Kidney Disease among Diabetes Mellitus and Hypertensive Patients at Jimma University Medical Center, Ethiopia. AOR, CKD, CKD-EPI, eGFR, GFR
40  2019 Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer. AH, aHR, BBs, CCBs, CI, TDs
41  2019 Potential cofactors in accidental food allergic reactions are frequently present but may not influence severity and occurrence. ARBs
42  2019 Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs). ARBs, CCBs, ORs
43  2019 Prescribing Patterns of Antihypertensives for Treatment-Naive Patients in South Korea: From Korean NHISS Claim Data. ARBs, BBs, CCBs
44  2019 Quality of Chronic Kidney Disease Management in Canadian Primary Care. ARBs, CKD
45  2019 Relationship Between Anaphylaxis and Use of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis of Observational Studies. BBs, CI, OR
46  2019 Renin-Angiotensin Inhibition in Combating Malignancy: A Review. ---
47  2019 Renin-angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival. ARBs, RAS, TAVR
48  2019 Renin-Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study. AMI, ARBs, CI, HF, IPW, LVEF, PSM, sHR
49  2019 Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure. AHF, ARBs
50  2019 Sex differences in antihypertensive drug use and blood pressure control. BP, CCBs, DUs
51  2019 Should ACE inhibitors and ARBs be used in combination in children? ARBs, BP, RAAS
52  2019 Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma. ARBs, HCC, RAS
53  2019 Target Doses of Heart Failure MedicalTherapy and Blood Pressure: Insights From the CHAMP-HF Registry. ARBs, ARNIs, BBs, CI, GDMT, HFrEF, SBP
54  2019 Temporal trends in optimal diabetic care and complications of elderly type 2 diabetes patients in Thailand: A nationwide study. ARBs, BP, HbA1c, LDL-C, T2DM
55  2019 The effect of topical ramipril and losartan cream in inhibiting scar formation. ARBs, p-Smad3, RAS, TGF-beta1
56  2019 The uses and expenses of antihypertensive medications among hypertensive adults. ARBs, BBs, CCBs, CI, TDs
57  2019 Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community. ARBs, HFpEF
58  2019 Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia. AOR, CI, NYHA
59  2019 Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats. ACE, Ang II, ANOVA, ARBs, BP, CCB, CKD, CMI, CVD, DBP, ELISA, KMI, LMI, MAP, PRC, RAS, REN, SBP, SHR, SNK-q test, VSA, VWA, WKY
60  2019 [Effects of clinical medicine on salt sensitivity hypertension: a systematic review and meta-analysis]. MD, RCTs
61  2018 A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA. CI, HF, HR
62  2018 ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies. MD
63  2018 ACE-inhibitors: a preventive measure for bone flap resorption after autologous cranioplasty? AC, BFR, EFP, VP
64  2018 Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis. AKI, ARBs, IRRs, LRTI, UTI
65  2018 Addition of Digoxin Improves Cardiac Function in Children With the Dilated Cardiomyopathy With Ataxia Syndrome: AMitochondrial Cardiomyopathy. DCMA, LVEF
66  2018 Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator. tPA
67  2018 Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. ---
68  2018 Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-beta1 pathways. TGF-beta1
69  2018 Angiotensin-converting Enzyme Inhibitors Decrease the Incidence of Radiation-induced Pneumonitis Among Lung Cancer Patients: A Systematic Review and Meta-analysis. ARBs, RP
70  2018 Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge. AMI, CV, HRs, RASIs
71  2018 Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury. AKI, ARBs, ESRD
72  2018 Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis. CIs
73  2018 Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study. ARBs, CI, DM, HBV, HCC, HCV, HR, HRs
74  2018 Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study. CI, HFrEF, HR
75  2018 Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. aHR, ARBs
76  2018 Comparative efficacy of individual renin-angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis. ARBs, DKD, ESRD, PROSPERO
77  2018 Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial. ARBs
78  2018 Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis. ARBs, CV, HF, MI, OR, RCTs, T2DM
79  2018 Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis. ARBs
80  2018 Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study. ARBs, CI, OR
81  2018 Drug prescribing during pregnancy in a central region of Italy, 2008-2012. ARBs, FDA
82  2018 Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes. ARBs, AVF, CCBs
83  2018 Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment. ABPM, ARBs, BPV, dCCBs
84  2018 Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: Ameta-analysis of randomized controlled trials
. ARBs, BUN, CI, CPM-Rheum, SCr, WMD
85  2018 Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke. AIS, EPCs
86  2018 Effects of clinical decision support and pharmacist prescribing authority on a therapeutic interchange program. ARBs, HMG-CoA RIs, TI
87  2018 Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies. AMI
88  2018 Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies. AMI, BP, HR, SMILE, TDs
89  2018 Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan. ARBs, ARNI, HF, HFrEF, NPS, RAAS, SNS
90  2018 Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study. CVD, ICPs
91  2018 How are patients with heart failure treated in primary care?
. ARBs, BBs, GAI-3, GPs, HFpEF, HFrEF, MRAs
92  2018 Hypotensive Drugs and Syncope Due to Orthostatic Hypotension in Older Adults with Dementia (Syncope and Dementia Study). RR
93  2018 Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE). AHF, AOR, ARBs, CI, Gulf CARE, LVEF
94  2018 Impact of Appointment-Based Medication Synchronization on Proportion of Days Covered for Chronic Medications. ABMS, ARBs, CMS, EQuIPP, NIDM, PDC
95  2018 Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction. AMI, ARBs, ARF, AT, CIs, CKD, HR, ITT
96  2018 Incipient Albuminuria in Persons with Newly Diagnosed Type 2 Diabetes Mellitus: A 5-Year Retrospective Cohort Study. ARBs, DM
97  2018 Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study. CI
98  2018 Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis. ARBs, ARNI, BBs, CrI, HFrEF, IVA, MRAs, NMA
99  2018 Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke. ARBs, i.v, mRS, rt-PA, sICH
100  2018 Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System. AF, AI, ARB, CI, ORs, RAAS